Synta Pharmaceuticals Corp. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 8 of 8 Posts
E Synta Pharmaceuticals Merges With Privately Held Madrigal
Article By: Terry Chrisomalis Thursday, April 14, 2016 10:34 PM EDT
Madrigal will own 64% of the combined company; the deal should finalize in Q3.
In this article: SNTA Also: GILD, ICPT, GALT, GLMD, CNAT
Read
Synta Pharmaceuticals, Madtrigal Pharmaceuticals Enter Merger Agreement
Article By: The Fly Thursday, April 14, 2016 8:37 AM EDT
Synta Pharmaceuticals and Madrigal Pharmaceuticals, a privately-held company, announced that they have entered into a definitive merger agreement under which Madrigal will merge with a wholly-owned subsidiary of Synta in an all-stock transaction.
In this article: SNTA
Read
E Synta Pharmaceuticals Drops Phase 3 Lung Cancer Trial
Article By: Terry Chrisomalis Thursday, October 22, 2015 5:15 AM EDT
Shares of Synta Pharmaceuticals tumbled 63% yesterday after the compnay stated, it has completely dropping its phase 3 lung cancer trial.
In this article: SNTA
Read
Heavy Insider Buying Could Signal Big Rallies For These 3 Stocks
Article By: Bret Jensen Tuesday, April 14, 2015 9:52 PM EDT
Here are a few small biotech stocks that have garnered considerable interest recently from notable investors as of late.
In this article: KERX, CGIX, SNTA
Read
Insider Trading Report Edition #224: Notable Buys And Sales
Article By: Asif Suria Monday, October 6, 2014 4:56 AM EDT
Welcome to edition 224 of Insider Weekends. Insider buying increased last week with insiders buying $72.32 million of stock compared to $30.92 million in the week prior.
In this article: ACN, AGCO, IRM, LGF, OPK, Y, SNTA, MU, UVSP, CVEO
Read
Synta Pharmaceuticals Corp To Gain Momentum In The Biopharmaceutical Industry
Article By: Dr. Hung Tran Tuesday, July 15, 2014 7:00 AM EDT
Synta Pharmaceuticals Corp is a biotechnology firm focused on the discovery, development and commercialization of small molecule drugs indicated for cancer and inflammatory diseases.
In this article: SNTA
Read
E Small Cap Report
Article By: E.B. Capital Markets Thursday, March 20, 2014 1:39 PM EDT
The highest scoring names in small cap from 1 year ago (3/20/2013) returned 3,708 bps more than the S&P 500. The best performers have been RAD up 255%, CAMP up 205%, JAZZ up 163%, MDSO up 127%, GBX up 109%, and HOMB up 90%.
In this article: CDI, CGX, CHE, CMO, CWT, EXAM, FSS, GBX, GTS, PGI, RAD, STRI, WWE, AFFY, ALIM, ANAC, BABY, CYBX, DXPE, DXYN, ECOL, FLDM, GERN, HOMB, HTWR, IRWD, IVAC, JAZZ, MDSO, MPWR, NLNK, PENX, PHMD, REDF, RTIX, SABA, SGMO, SILC, SNTA, VASC, AGYS, AMED, ANIK, BJRI, BLDR, CAMP, CENX, CFNL, DIOD, ELNK, FINL, FORM, GLRE, LCAV, SNHY, STFC, TQNT, UEIC, UNTD, WIRE, XRTX, EBIX, KERX
Read
E Small Cap Report - Best And Worst
Article By: E.B. Capital Markets Thursday, March 13, 2014 7:43 PM EDT
Our weekly best and worst reports show you stocks with the best potential returns over the coming 6 to 12 months.
In this article: CDE, CHE, GBX, GOL, GTS, HXM, HZO, RSHC, STRI, AFFY, PENX, REDF, SNTA, SPPI, VASC, AGYS, BLDR, CFNL, DIOD, ELNK, FINL, LYTS, SNHY, SRDX, UNTD, WIRE, EBIX
Read
1 to 8 of 8 Posts